Table of Contents 1 Anti-PD-1 Antibody Market Overview 1.1 Product Overview and Scope of Anti-PD-1 Antibody 1.2 Anti-PD-1 Antibody Segment by Type 1.2.1 Global Anti-PD-1 Antibody Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Monoclonal 1.2.3 Polyclonal 1.3 Anti-PD-1 Antibody Segment by Application 1.3.1 Anti-PD-1 Antibody Sales Comparison by Application: 2020 VS 2026 1.3.2 IHC-P 1.3.3 ICC/IF 1.3.4 WB 1.3.5 Flow Cytometry 1.3.6 ELISA 1.4 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts 1.4.1 Global Anti-PD-1 Antibody Revenue 2015-2026 1.4.2 Global Anti-PD-1 Antibody Sales 2015-2026 1.4.3 Anti-PD-1 Antibody Market Size by Region: 2020 Versus 2026 2 Global Anti-PD-1 Antibody Market Competition by Manufacturers 2.1 Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2015-2020) 2.2 Global Anti-PD-1 Antibody Revenue Share by Manufacturers (2015-2020) 2.3 Global Anti-PD-1 Antibody Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Anti-PD-1 Antibody Manufacturing Sites, Area Served, Product Type 2.5 Anti-PD-1 Antibody Market Competitive Situation and Trends 2.5.1 Anti-PD-1 Antibody Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Anti-PD-1 Antibody Players (Opinion Leaders) 3 Anti-PD-1 Antibody Retrospective Market Scenario by Region 3.1 Global Anti-PD-1 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Anti-PD-1 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Anti-PD-1 Antibody Market Facts & Figures by Country 3.3.1 North America Anti-PD-1 Antibody Sales by Country 3.3.2 North America Anti-PD-1 Antibody Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Anti-PD-1 Antibody Market Facts & Figures by Country 3.4.1 Europe Anti-PD-1 Antibody Sales by Country 3.4.2 Europe Anti-PD-1 Antibody Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Region 3.5.1 Asia Pacific Anti-PD-1 Antibody Sales by Region 3.5.2 Asia Pacific Anti-PD-1 Antibody Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Anti-PD-1 Antibody Market Facts & Figures by Country 3.6.1 Latin America Anti-PD-1 Antibody Sales by Country 3.6.2 Latin America Anti-PD-1 Antibody Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Country 3.7.1 Middle East and Africa Anti-PD-1 Antibody Sales by Country 3.7.2 Middle East and Africa Anti-PD-1 Antibody Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Anti-PD-1 Antibody Historic Market Analysis by Type 4.1 Global Anti-PD-1 Antibody Sales Market Share by Type (2015-2020) 4.2 Global Anti-PD-1 Antibody Revenue Market Share by Type (2015-2020) 4.3 Global Anti-PD-1 Antibody Price Market Share by Type (2015-2020) 4.4 Global Anti-PD-1 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Anti-PD-1 Antibody Historic Market Analysis by Application 5.1 Global Anti-PD-1 Antibody Sales Market Share by Application (2015-2020) 5.2 Global Anti-PD-1 Antibody Revenue Market Share by Application (2015-2020) 5.3 Global Anti-PD-1 Antibody Price by Application (2015-2020) 6 Company Profiles and Key Figures in Anti-PD-1 Antibody Business 6.1 Bio X Cell 6.1.1 Corporation Information 6.1.2 Bio X Cell Description, Business Overview and Total Revenue 6.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Bio X Cell Products Offered 6.1.5 Bio X Cell Recent Development 6.2 Thermo Fisher 6.2.1 Thermo Fisher Anti-PD-1 Antibody Production Sites and Area Served 6.2.2 Thermo Fisher Description, Business Overview and Total Revenue 6.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Thermo Fisher Products Offered 6.2.5 Thermo Fisher Recent Development 6.3 InvivoGen 6.3.1 InvivoGen Anti-PD-1 Antibody Production Sites and Area Served 6.3.2 InvivoGen Description, Business Overview and Total Revenue 6.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.3.4 InvivoGen Products Offered 6.3.5 InvivoGen Recent Development 6.4 BioVision Inc 6.4.1 BioVision Inc Anti-PD-1 Antibody Production Sites and Area Served 6.4.2 BioVision Inc Description, Business Overview and Total Revenue 6.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.4.4 BioVision Inc Products Offered 6.4.5 BioVision Inc Recent Development 6.5 Abcam 6.5.1 Abcam Anti-PD-1 Antibody Production Sites and Area Served 6.5.2 Abcam Description, Business Overview and Total Revenue 6.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Abcam Products Offered 6.5.5 Abcam Recent Development 6.6 Bristol-Myers Squibb (BMS) 6.6.1 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Production Sites and Area Served 6.6.2 Bristol-Myers Squibb (BMS) Description, Business Overview and Total Revenue 6.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Bristol-Myers Squibb (BMS) Products Offered 6.6.5 Bristol-Myers Squibb (BMS) Recent Development 6.7 Merck 6.6.1 Merck Anti-PD-1 Antibody Production Sites and Area Served 6.6.2 Merck Description, Business Overview and Total Revenue 6.6.3 Merck Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Merck Products Offered 6.7.5 Merck Recent Development 6.8 Ono Pharmaceutical Co., Ltd 6.8.1 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Production Sites and Area Served 6.8.2 Ono Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue 6.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Ono Pharmaceutical Co., Ltd Products Offered 6.8.5 Ono Pharmaceutical Co., Ltd Recent Development 6.9 Lilly 6.9.1 Lilly Anti-PD-1 Antibody Production Sites and Area Served 6.9.2 Lilly Description, Business Overview and Total Revenue 6.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Lilly Products Offered 6.9.5 Lilly Recent Development 6.10 Chugai Pharmaceutical Co., Ltd 6.10.1 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Production Sites and Area Served 6.10.2 Chugai Pharmaceutical Co., Ltd Description, Business Overview and Total Revenue 6.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Chugai Pharmaceutical Co., Ltd Products Offered 6.10.5 Chugai Pharmaceutical Co., Ltd Recent Development 6.11 BeiGene 6.11.1 BeiGene Anti-PD-1 Antibody Production Sites and Area Served 6.11.2 BeiGene Anti-PD-1 Antibody Description, Business Overview and Total Revenue 6.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.11.4 BeiGene Products Offered 6.11.5 BeiGene Recent Development 6.12 Abbvie 6.12.1 Abbvie Anti-PD-1 Antibody Production Sites and Area Served 6.12.2 Abbvie Anti-PD-1 Antibody Description, Business Overview and Total Revenue 6.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Abbvie Products Offered 6.12.5 Abbvie Recent Development 6.13 TG Therapeutics, Inc 6.13.1 TG Therapeutics, Inc Anti-PD-1 Antibody Production Sites and Area Served 6.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Description, Business Overview and Total Revenue 6.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.13.4 TG Therapeutics, Inc Products Offered 6.13.5 TG Therapeutics, Inc Recent Development 6.14 Novartis 6.14.1 Novartis Anti-PD-1 Antibody Production Sites and Area Served 6.14.2 Novartis Anti-PD-1 Antibody Description, Business Overview and Total Revenue 6.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.14.4 Novartis Products Offered 6.14.5 Novartis Recent Development 6.15 Arcus Biosciences 6.15.1 Arcus Biosciences Anti-PD-1 Antibody Production Sites and Area Served 6.15.2 Arcus Biosciences Anti-PD-1 Antibody Description, Business Overview and Total Revenue 6.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Arcus Biosciences Products Offered 6.15.5 Arcus Biosciences Recent Development 6.16 Sino Biological Inc 6.16.1 Sino Biological Inc Anti-PD-1 Antibody Production Sites and Area Served 6.16.2 Sino Biological Inc Anti-PD-1 Antibody Description, Business Overview and Total Revenue 6.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Sino Biological Inc Products Offered 6.16.5 Sino Biological Inc Recent Development 6.17 3SBio Inc 6.17.1 3SBio Inc Anti-PD-1 Antibody Production Sites and Area Served 6.17.2 3SBio Inc Anti-PD-1 Antibody Description, Business Overview and Total Revenue 6.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.17.4 3SBio Inc Products Offered 6.17.5 3SBio Inc Recent Development 7 Anti-PD-1 Antibody Manufacturing Cost Analysis 7.1 Anti-PD-1 Antibody Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Anti-PD-1 Antibody 7.4 Anti-PD-1 Antibody Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Anti-PD-1 Antibody Distributors List 8.3 Anti-PD-1 Antibody Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Anti-PD-1 Antibody Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Anti-PD-1 Antibody by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Type (2021-2026) 10.2 Anti-PD-1 Antibody Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Anti-PD-1 Antibody by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Application (2021-2026) 10.3 Anti-PD-1 Antibody Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Anti-PD-1 Antibody by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Region (2021-2026) 10.4 North America Anti-PD-1 Antibody Estimates and Projections (2021-2026) 10.5 Europe Anti-PD-1 Antibody Estimates and Projections (2021-2026) 10.6 Asia Pacific Anti-PD-1 Antibody Estimates and Projections (2021-2026) 10.7 Latin America Anti-PD-1 Antibody Estimates and Projections (2021-2026) 10.8 Middle East and Africa Anti-PD-1 Antibody Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Anti-PD-1 Antibody Sales (Kg) Growth Rate Comparison by Type (2015-2026) Table 2. Global Anti-PD-1 Antibody Sales (Kg) Comparison by Application: 2020 VS 2026 Table 3. Global Anti-PD-1 Antibody Market Size by Type (Kg) (US$ Million) (2020 VS 2026) Table 4. Global Key Anti-PD-1 Antibody Manufacturers Covered in This Study Table 5. Global Anti-PD-1 Antibody Sales (Kg) by Manufacturers (2015-2020) Table 6. Global Anti-PD-1 Antibody Sales Share by Manufacturers (2015-2020) Table 7. Global Anti-PD-1 Antibody Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Anti-PD-1 Antibody Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Anti-PD-1 Antibody Average Price (USD/g) of Key Manufacturers (2015-2020) Table 10. Manufacturers Anti-PD-1 Antibody Sales Sites and Area Served Table 11. Manufacturers Anti-PD-1 Antibody Product Types Table 12. Global Anti-PD-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Anti-PD-1 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 Antibody as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Anti-PD-1 Antibody Players Table 16. Global Anti-PD-1 Antibody Sales (Kg) by Region (2015-2020) Table 17. Global Anti-PD-1 Antibody Sales Market Share by Region (2015-2020) Table 18. Global Anti-PD-1 Antibody Revenue (Million US$) by Region (2015-2020) Table 19. Global Anti-PD-1 Antibody Revenue Market Share by Region (2015-2020) Table 20. North America Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg) Table 21. North America Anti-PD-1 Antibody Sales Market Share by Country (2015-2020) Table 22. North America Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million) Table 23. North America Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020) Table 24. Europe Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg) Table 25. Europe Anti-PD-1 Antibody Sales Market Share by Country (2015-2020) Table 26. Europe Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Anti-PD-1 Antibody Sales by Region (2015-2020) (Kg) Table 29. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Anti-PD-1 Antibody Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region (2015-2020) Table 32. Latin America Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg) Table 33. Latin America Anti-PD-1 Antibody Sales Market Share by Country (2015-2020) Table 34. Latin America Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2015-2020) (Kg) Table 37. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Anti-PD-1 Antibody Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country (2015-2020) Table 40. Global Anti-PD-1 Antibody Sales (Kg) by Type (2015-2020) Table 41. Global Anti-PD-1 Antibody Sales Share by Type (2015-2020) Table 42. Global Anti-PD-1 Antibody Revenue (Million US$) by Type (2015-2020) Table 43. Global Anti-PD-1 Antibody Revenue Share by Type (2015-2020) Table 44. Global Anti-PD-1 Antibody Price (USD/g) by Type (2015-2020) Table 45. Global Anti-PD-1 Antibody Sales (Kg) by Application (2015-2020) Table 46. Global Anti-PD-1 Antibody Sales Market Share by Application (2015-2020) Table 47. Global Anti-PD-1 Antibody Sales Growth Rate by Application (2015-2020) Table 48. Bio X Cell Anti-PD-1 Antibody Corporation Information Table 49. Bio X Cell Description and Business Overview Table 50. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 51. Bio X Cell Main Product Table 52. Bio X Cell Recent Development Table 53. Thermo Fisher Anti-PD-1 Antibody Corporation Information Table 54. Thermo Fisher Corporation Information Table 55. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 56. Thermo Fisher Main Product Table 57. Thermo Fisher Recent Development Table 58. InvivoGen Anti-PD-1 Antibody Corporation Information Table 59. InvivoGen Corporation Information Table 60. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 61. InvivoGen Main Product Table 62. InvivoGen Recent Development Table 63. BioVision Inc Anti-PD-1 Antibody Corporation Information Table 64. BioVision Inc Corporation Information Table 65. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 66. BioVision Inc Main Product Table 67. BioVision Inc Recent Development Table 68. Abcam Anti-PD-1 Antibody Corporation Information Table 69. Abcam Corporation Information Table 70. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 71. Abcam Main Product Table 72. Abcam Recent Development Table 73. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Corporation Information Table 74. Bristol-Myers Squibb (BMS) Corporation Information Table 75. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 76. Bristol-Myers Squibb (BMS) Main Product Table 77. Bristol-Myers Squibb (BMS) Recent Development Table 78. Merck Anti-PD-1 Antibody Corporation Information Table 79. Merck Corporation Information Table 80. Merck Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 81. Merck Main Product Table 82. Merck Recent Development Table 83. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Corporation Information Table 84. Ono Pharmaceutical Co., Ltd Corporation Information Table 85. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 86. Ono Pharmaceutical Co., Ltd Main Product Table 87. Ono Pharmaceutical Co., Ltd Recent Development Table 88. Lilly Anti-PD-1 Antibody Corporation Information Table 89. Lilly Corporation Information Table 90. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 91. Lilly Main Product Table 92. Lilly Recent Development Table 93. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Corporation Information Table 94. Chugai Pharmaceutical Co., Ltd Corporation Information Table 95. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 96. Chugai Pharmaceutical Co., Ltd Main Product Table 97. Chugai Pharmaceutical Co., Ltd Recent Development Table 98. BeiGene Anti-PD-1 Antibody Corporation Information Table 99. BeiGene Corporation Information Table 100. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 101. BeiGene Main Product Table 102. BeiGene Recent Development Table 103. Abbvie Anti-PD-1 Antibody Corporation Information Table 104. Abbvie Corporation Information Table 105. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 106. Abbvie Main Product Table 107. Abbvie Recent Development Table 108. TG Therapeutics, Inc Anti-PD-1 Antibody Corporation Information Table 109. TG Therapeutics, Inc Corporation Information Table 110. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 111. TG Therapeutics, Inc Main Product Table 112. TG Therapeutics, Inc Recent Development Table 113. Novartis Anti-PD-1 Antibody Corporation Information Table 114. Novartis Corporation Information Table 115. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 116. Novartis Main Product Table 117. Novartis Recent Development Table 118. Arcus Biosciences Anti-PD-1 Antibody Corporation Information Table 119. Arcus Biosciences Corporation Information Table 120. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 121. Arcus Biosciences Main Product Table 122. Arcus Biosciences Recent Development Table 123. Sino Biological Inc Anti-PD-1 Antibody Corporation Information Table 124. Sino Biological Inc Corporation Information Table 125. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 126. Sino Biological Inc Main Product Table 127. Sino Biological Inc Recent Development Table 128. 3SBio Inc Anti-PD-1 Antibody Corporation Information Table 129. 3SBio Inc Corporation Information Table 130. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (Million US$), Price (USD/g) and Gross Margin (2015-2020) Table 131. 3SBio Inc Main Product Table 132. 3SBio Inc Recent Development Table 133. Sales Base and Market Concentration Rate of Raw Material Table 134. Key Suppliers of Raw Materials Table 135. Anti-PD-1 Antibody Distributors List Table 136. Anti-PD-1 Antibody Customers List Table 137. Market Key Trends Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 139. Key Challenges Table 140. Global Anti-PD-1 Antibody Sales (Kg) Forecast by Type (2021-2026) Table 141. Global Anti-PD-1 Antibody Sales Market Share Forecast by Type (2021-2026) Table 142. Global Anti-PD-1 Antibody Revenue (Million US$) Forecast by Type (2021-2026) Table 143. Global Anti-PD-1 Antibody Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 144. Global Anti-PD-1 Antibody Sales (Kg) Forecast by Application (2021-2026) Table 145. Global Anti-PD-1 Antibody Revenue (Million US$) Forecast by Application (2021-2026) Table 146. Global Anti-PD-1 Antibody Sales (Kg) Forecast by Region (2021-2026) Table 147. Global Anti-PD-1 Antibody Sales Market Share Forecast by Region (2021-2026) Table 148. Global Anti-PD-1 Antibody Revenue Forecast by Region (2021-2026) (US$ Million) Table 149. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Region (2021-2026) Table 150. Research Programs/Design for This Report Table 151. Key Data Information from Secondary Sources Table 152. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Anti-PD-1 Antibody Figure 2. Global Anti-PD-1 Antibody Sales Market Share by Type: 2020 VS 2026 Figure 3. Monoclonal Product Picture Figure 4. Polyclonal Product Picture Figure 5. Global Anti-PD-1 Antibody Consumption Market Share by Application: 2020 VS 2026 Figure 6. IHC-P Figure 7. ICC/IF Figure 8. WB Figure 9. Flow Cytometry Figure 10. ELISA Figure 11. Global Anti-PD-1 Antibody Market Size 2015-2026 (US$ Million) Figure 12. Global Anti-PD-1 Antibody Sales Capacity (Kg) (2015-2026) Figure 13. Global Anti-PD-1 Antibody Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Anti-PD-1 Antibody Sales Share by Manufacturers in 2020 Figure 15. Global Anti-PD-1 Antibody Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Anti-PD-1 Antibody Revenue in 2019 Figure 17. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Anti-PD-1 Antibody Sales Market Share by Region (2015-2020) Figure 19. Global Anti-PD-1 Antibody Sales Market Share by Region in 2019 Figure 20. Global Anti-PD-1 Antibody Revenue Market Share by Region (2015-2020) Figure 21. Global Anti-PD-1 Antibody Revenue Market Share by Region in 2019 Figure 22. North America Anti-PD-1 Antibody Sales Market Share by Country in 2019 Figure 23. North America Anti-PD-1 Antibody Revenue Market Share by Country in 2019 Figure 24. U.S. Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 25. U.S. Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 27. Canada Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Anti-PD-1 Antibody Sales Market Share by Country in 2019 Figure 29. Europe Anti-PD-1 Antibody Revenue Market Share by Country in 2019 Figure 30. Germany Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 31. Germany Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 33. France Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 35. U.K. Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 37. Italy Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 39. Russia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region in 2019 Figure 41. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region in 2019 Figure 42. China Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 43. China Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 45. Japan Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 47. South Korea Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 49. India Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 51. Australia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 53. Taiwan Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 55. Indonesia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 57. Thailand Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 59. Malaysia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 61. Philippines Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 63. Vietnam Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Anti-PD-1 Antibody Sales Market Share by Country in 2019 Figure 65. Latin America Anti-PD-1 Antibody Revenue Market Share by Country in 2019 Figure 66. Mexico Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 67. Mexico Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 69. Brazil Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 71. Argentina Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country in 2019 Figure 74. Turkey Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 75. Turkey Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 77. Saudi Arabia Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Anti-PD-1 Antibody Sales Growth Rate (2015-2020) (Kg) Figure 79. U.A.E Anti-PD-1 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Anti-PD-1 Antibody by Type (2015-2020) Figure 81. Sales Market Share of Anti-PD-1 Antibody by Type in 2019 Figure 82. Revenue Share of Anti-PD-1 Antibody by Type (2015-2020) Figure 83. Revenue Market Share of Anti-PD-1 Antibody by Type in 2019 Figure 84. Global Anti-PD-1 Antibody Sales Growth by Type (2015-2020) (Kg) Figure 85. Global Anti-PD-1 Antibody Sales Market Share by Application (2015-2020) Figure 86. Global Anti-PD-1 Antibody Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Anti-PD-1 Antibody by Application (2015-2020) Figure 88. Global Revenue Share of Anti-PD-1 Antibody by Application in 2020 Figure 89. Bio X Cell Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Thermo Fisher Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. BioVision Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Abcam Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Bristol-Myers Squibb (BMS) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Ono Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Chugai Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. BeiGene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Abbvie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. TG Therapeutics, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Arcus Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Sino Biological Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. 3SBio Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Price Trend of Key Raw Materials Figure 107. Manufacturing Cost Structure of Anti-PD-1 Antibody Figure 108. Manufacturing Process Analysis of Anti-PD-1 Antibody Figure 109. Anti-PD-1 Antibody Industrial Chain Analysis Figure 110. Channels of Distribution Figure 111. Distributors Profiles Figure 112. Porter's Five Forces Analysis Figure 113. North America Anti-PD-1 Antibody Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 114. North America Anti-PD-1 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 115. Europe Anti-PD-1 Antibody Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 116. Europe Anti-PD-1 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 117. Latin America Anti-PD-1 Antibody Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 118. Latin America Anti-PD-1 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 119. Middle East and Africa Anti-PD-1 Antibody Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 120. Middle East and Africa Anti-PD-1 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 121. Asia Pacific Anti-PD-1 Antibody Sales (Kg) and Growth Rate Forecast (2021-2026) Figure 122. Asia Pacific Anti-PD-1 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 123. Bottom-up and Top-down Approaches for This Report Figure 124. Data Triangulation Figure 125. Key Executives Interviewed

Bio X Cell Thermo Fisher InvivoGen BioVision Inc Abcam Bristol-Myers Squibb (BMS) Merck Ono Pharmaceutical Co., Ltd Lilly Chugai Pharmaceutical Co., Ltd BeiGene Abbvie TG Therapeutics, Inc Novartis Arcus Biosciences Sino Biological Inc 3SBio Inc